L5: Prostate Cancer Flashcards
1
Q
Anatomical Overview of Prostate
A
2
Q
Epidemeology of Prostate Cancer
A
3
Q
Genitourinary Cancers
- % of solid tumors
A
4
Q
Genitourinary Cancers
- Incidence of Mortality in each
A
5
Q
RF for Prostate Cancer
A
6
Q
RF for Prostate Cancer
- Non modifiable
A
7
Q
Non Modifiable RF for Prostate Cancer
- Age
A
8
Q
Non Modifiable RF for Prostate Cancer
- Race
A
9
Q
Non Modifiable RF for Prostate Cancer
- Family Hx
A
10
Q
Non Modifiable RF for Prostate Cancer
- Nationality
A
11
Q
Non Modifiable RF for Prostate Cancer
- Genetics
A
12
Q
Modifiable RF for Prostate Cancer
A
13
Q
Precancerous Lesions in Prostate Cancer
A
14
Q
Precancerous Lesions in Prostate Cancer
- PIN
A
15
Q
Precancerous Lesions in Prostate Cancer
- PIA
A
16
Q
Classification & Sites of Prostate Cancer
A
17
Q
Classification & Sites of Prostate Cancer
- Epithelial Tumors
A
18
Q
Classification & Sites of Prostate Cancer
- Stromal Tumors
A
19
Q
Classification & Sites of Prostate Cancer
- Secondary Cause
A
20
Q
Classification & Sites of Prostate Cancer
- Most Common Type
A
21
Q
Microscopic Examination of Prostate Cancer
A
22
Q
Microscopic Examination of Prostate Cancer
- Based On
A
23
Q
Microscopic Examination of Prostate Cancer
- Gleason Grading System
A
24
Q
Staging of Prostate Cancer
A
25
Staging of **Prostate Cancer**
- T
26
Staging of **Prostate Cancer**
- N
27
Staging of **Prostate Cancer**
- M
28
Spread of **Prostate Cancer**
29
Spread of **Prostate Cancer**
- Local
30
Spread of **Prostate Cancer**
- Lymphatic
31
Spread of **Prostate Cancer**
- Hematogenous
32
Spread of **Prostate Cancer**
- Most common Site of Hematogenous Mets
33
Dx of **Prostate Cancer**
34
Dx of **Prostate Cancer**
- CP
35
CP of **Prostate Cancer**
- Asymptomatic
36
CP of **Prostate Cancer**
- Manifest
37
CP of **Prostate Cancer**
- Complications
38
CP of **Prostate Cancer**
- Metastasis
39
Screening for **Prostate Cancer**
- Why?
- For Whom?
- How?
40
DRE in **Prostate Cancer**
41
Findings in **DRE in Prostate Cancer**
42
Size in **DRE in Prostate Cancer**
43
Accuracy of **DRE in Prostate Cancer**
44
False Positive in **DRE in Prostate Cancer**
45
False Negative in **DRE in Prostate Cancer**
46
INVx for **Prostate Cancer**
47
INVx for **Prostate Cancer**
- PSA
48
Def of PSA
49
Normal Values of **PSA**
50
levels of PSA Over Time
- Normal
- BPH
- Prostate Cancer
51
Factors increasing PSA
52
Factors Decreaseing PSA
53
Importance of **PSA**
54
Importance of **PSA**
- Diagnosis
55
Importance of **PSA**
- Staging & TTT Decision
56
Importance of **PSA**
- Follow Up
57
Follow Up by **PSA**
58
Follow Up by **PSA**
- Surgery
59
Follow Up by **PSA**
- radiotherapy
60
Follow Up by **PSA**
- Metastatic Cancer
61
Other Tumor Markers for **Prostate Cancer**
62
TRUS in **Prostate Cancer**
63
Value of TRUS in **Prostate Cancer**
64
False Positive in TRUS in **Prostate Cancer**
65
False Negative in TRUS in **Prostate Cancer**
66
Types of **Tissue Biopsy in Prostate Cx**
67
Indications of **Tissue Biopsy in Prostate Cx**
68
Indications of **Tissue Biopsy in Prostate Cx**
- Absolute
69
Indications of **Tissue Biopsy in Prostate Cx**
- Relative Indications
70
Interpretation of **Age-Adjusted PSA**
71
Def of **PSA Velocity**
72
Interpretation of **PSA Velocity**
73
Rationale of **Free PSA**
74
Interpretation of **Free PSA**
75
Rationale of **PSA Density**
76
Def of **PSA Density**
77
Interpertation of **PSA Density**
78
Imaging in **Prostate Cx**
79
Imaging in **Prostate Cx**
- CT, MRI
80
Indications of CT,MRI in Prostate Cx
81
Role of **Pelvic Lymphadenectomy in Prostate Cx**
82
Bone Scan in **Prostate Cx**
83
Indications of Bone Scan in **Prostate Cx**
84
Why is Bone Scan Mandatory in Prostate Cx?
85
**Methods of Therapy in Organ-Confined Prostate Cx**
86
**Methods of Therapy in Prostate Cx**
- T1a
87
**Methods of Therapy in Prostate Cx**
- T1b, T1c, T2
88
**Methods of Therapy in Prostate Cx**
- T3
89
**Methods of Therapy in Prostate Cx**
- Metastatic
90
**Methods of Therapy in Prostate Cx**
- Low Risk
91
**Methods of Therapy in Prostate Cx**
- Moderat Risk
92
**Methods of Therapy in Prostate Cx**
- High Risk
93
Methods of TTT of **Prosate Cx**
94
Methods of TTT of **Prosate Cx**
- Watchful Waiting
95
Methods of TTT of **Prosate Cx**
- Radical Prostatectomy
96
Methods of TTT of **Prosate Cx**
- Radiotherapy
97
Methods of TTT of **Prosate Cx**
- Depend on
98
Methods of **Watchful Waiting** in Prostate Cx
99
Indications of **Watchful Waiting** in Prostate Cx
100
CI of **Watchful Waiting** in Prostate Cx
101
Advantages of **Watchful Waiting** in Prostate Cx
102
Disadvantages of **Watchful Waiting** in Prostate Cx
103
**Watchful Waiting** in Prostate Cx
- NB
104
Indications of **Radical Prostatectomy** in Prostate Cx
105
CI of **Radical Prostatectomy** in Prostate Cx
106
Advanatages of **Radical Prostatectomy** in Prostate Cx
107
Disadvantages of **Radical Prostatectomy** in Prostate Cx
108
Method of **External Radiation** in prostate Cx
109
Indications of **External Radiation** in prostate Cx
110
CI in **External Radiation** in prostate Cx
111
Advanatges of **External Radiation** in prostate Cx
112
Disadvantages of **External Radiation** in prostate Cx
113
**External Radiation** in prostate Cx
- NB (Techniques)
114
Indications of **Brachytherapy** in Prostate Cx
115
CI of **Brachytherapy** in Prostate Cx
116
Advantages of **Brachytherapy** in Prostate Cx
117
Disadvantages of **Brachytherapy** in Prostate Cx
118
TTT options in **Symptomatic Metastatic Disease**
119
Indications of Hormonal TTT of **Prostate Cx**
120
Pathophysiology of Hormonal TTT of **Prostate Cx**
121
Lines of Hormonal TTT of **Prostate Cx**
122
Results of Androgen Removal in TTT of Prostate Cx
123
Medications used in **Hormonal TTT of Prostate Cx**
124
**Hormonal TTT of Prostate Cx**
- LHRH Analogues
125
**Hormonal TTT of Prostate Cx**
- Antiandrogenic
126
Finasteride & bicalutamide as primary hormonal therapy in advanced adenocarcinoma of the prostate
127
Significance of **HRPC**
128
TTT of **HRPC**
129
TTT of **HRPC**
- Cytotoxic Chemo
130
TTT of **HRPC**
- Bisphosphonate
